These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan. Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK Eur J Pharmacol; 1990 Mar; 178(3):313-20. PubMed ID: 1971220 [TBL] [Abstract][Full Text] [Related]
3. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin. Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK Eur J Pharmacol; 1989 Aug; 167(3):375-83. PubMed ID: 2572435 [TBL] [Abstract][Full Text] [Related]
4. Sub-picogram determination of serotonin using HPLC with electrochemical detection for microdialysis studies of serotonin release. Bradberry CW; Sprouse JS; Aghajanian GK; Roth RH Adv Exp Med Biol; 1991; 294():81-9. PubMed ID: 1685295 [No Abstract] [Full Text] [Related]
5. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: comparison between dorsal and median raphe 5-HT systems. Gartside SE; McQuade R; Sharp T Neuropharmacology; 1997; 36(11-12):1697-703. PubMed ID: 9517441 [TBL] [Abstract][Full Text] [Related]
6. Lack of neurotoxicity after intra-raphe micro-injections of MDMA ("ecstasy"). Paris JM; Cunningham KA NIDA Res Monogr; 1990; 105():333-4. PubMed ID: 1715034 [No Abstract] [Full Text] [Related]
8. Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA. Gollamudi R; Ali SF; Lipe G; Newport G; Webb P; Lopez M; Leakey JE; Kolta M; Slikker W Neurotoxicology; 1989; 10(3):455-66. PubMed ID: 2576302 [TBL] [Abstract][Full Text] [Related]
9. Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Johnson MP; Hoffman AJ; Nichols DE Eur J Pharmacol; 1986 Dec; 132(2-3):269-76. PubMed ID: 2880735 [TBL] [Abstract][Full Text] [Related]
10. Effects of repeated 3,4-methylenedioxymethamphetamine administration on neurotransmitter efflux and sensory-evoked discharge in the ventral posterior medial thalamus. Starr MA; Page ME; Waterhouse BD J Pharmacol Exp Ther; 2012 Jan; 340(1):73-82. PubMed ID: 21984836 [TBL] [Abstract][Full Text] [Related]
11. Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA). Paris JM; Cunningham KA Brain Res Bull; 1992 Jan; 28(1):115-9. PubMed ID: 1347247 [TBL] [Abstract][Full Text] [Related]
12. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents. Hekmatpanah CR; Peroutka SJ Eur J Pharmacol; 1990 Feb; 177(1-2):95-8. PubMed ID: 1971219 [TBL] [Abstract][Full Text] [Related]
13. Effects of a selective 5-HT2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphe nucleus and 5-HT release and metabolism in the frontal cortex. Wright IK; Garratt JC; Marsden CA Br J Pharmacol; 1990 Feb; 99(2):221-2. PubMed ID: 1691671 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin. Gazzara RA; Takeda H; Cho AK; Howard SG Eur J Pharmacol; 1989 Sep; 168(2):209-17. PubMed ID: 2575036 [TBL] [Abstract][Full Text] [Related]
15. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats. Mokler DJ; Robinson SE; Rosecrans JA Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440 [TBL] [Abstract][Full Text] [Related]
16. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Gough B; Ali SF; Slikker W; Holson RR Pharmacol Biochem Behav; 1991 Jul; 39(3):619-23. PubMed ID: 1723797 [TBL] [Abstract][Full Text] [Related]
17. Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo. Gartside SE; McQuade R; Sharp T J Pharmacol Exp Ther; 1996 Oct; 279(1):277-83. PubMed ID: 8859004 [TBL] [Abstract][Full Text] [Related]
18. MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system. Pan HS; Wang RY Brain Res; 1991 Jan; 539(2):332-6. PubMed ID: 1675911 [TBL] [Abstract][Full Text] [Related]